Related Experiment Video
Updated: Aug 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2
Laura D Zambrano1, Kathleen N Ly1, Ruth Link-Gelles1,2
1From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
Multisystem inflammatory syndrome in children (MIS-C) disproportionately affects minority children. Non-Hispanic Black children and those in high social vulnerability areas face increased MIS-C risk, highlighting disparities in pediatric health outcomes.
Area of Science:
- Pediatric Infectious Diseases
- Public Health
- Epidemiology
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a severe complication linked to SARS-CoV-2.
- MIS-C disproportionately impacts racial and ethnic minority children, indicating significant health disparities.
Purpose of the Study:
- To investigate risk factors contributing to MIS-C.
- To understand the underlying causes of MIS-C disparities in children.
Main Methods:
- A case-control study compared 241 MIS-C cases with 817 SARS-CoV-2-positive controls.
- Risk factors including race, ethnicity, social vulnerability index (SVI), insurance, and weight-for-age were analyzed.
- Mixed-effects multivariable logistic regression was employed to assess risk factors.
Main Results:
- Non-Hispanic Black children had a higher likelihood of MIS-C (aOR: 2.07).
- Higher SVI tertiles (aOR: 1.88-2.03) and being previously healthy (aOR: 1.64) were independent risk factors.
- Cases and controls showed similar distributions in sex, age, and U.S. census region.
Conclusions:
- Non-Hispanic Black children are more prone to developing MIS-C.
- Further research into immunologic and environmental factors is necessary to explain MIS-C disparities.
Background:
Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related complication that has disproportionately affected racial/ethnic minority children. We conducted a pilot study to investigate risk factors for MIS-C aiming to understand MIS-C disparities.
Methods:
This case-control study included MIS-C cases and SARS-CoV-2-positive outpatient controls less than 18 years old frequency-matched 4:1 to cases by age group and site. Patients hospitalized with MIS-C were admitted between March 16 and October 2, 2020, across 17 pediatric hospitals. We evaluated race, ethnicity, social vulnerability index (SVI), insurance status, weight-for-age and underlying medical conditions as risk factors using mixed effects multivariable logistic regression.
Results:
We compared 241 MIS-C cases with 817 outpatient SARS-CoV-2-positive at-risk controls. Cases and controls had similar sex, age and U.S. census region distribution. MIS-C patients were more frequently previously healthy, non-Hispanic Black, residing in higher SVI areas, and in the 95th percentile or higher for weight-for-age. In the multivariable analysis, the likelihood of MIS-C was higher among non-Hispanic Black children [adjusted odds ratio (aOR): 2.07; 95% CI: 1.23-3.48]. Additionally, SVI in the 2nd and 3rd tertiles (aOR: 1.88; 95% CI: 1.18-2.97 and aOR: 2.03; 95% CI: 1.19-3.47, respectively) were independent factors along with being previously healthy (aOR: 1.64; 95% CI: 1.18-2.28).
Conclusions:
In this study, non-Hispanic Black children were more likely to develop MIS-C after adjustment for sociodemographic factors, underlying medical conditions, and weight-for-age. Investigation of the potential contribution of immunologic, environmental, and other factors is warranted.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Myocarditis II: Clinical Features and Diagnostic Tests